Future Growth of Immunoglobulin Market By Top Leading Companies and Manufacturers With Industry Forecast [2017-2023]

Global Immunoglobulin Market was valued at $8,374 million in 2016, and is projected to reach $13,619 million by 2023, registering a CAGR of 7.3% from 2017 to 2023. Immunoglobulin is a protein produced by plasma cells and other lymphocytes. They are highly complex entities that exert their immunomodulatory effect on the different components of the immune system. They are obtained from blood by fractionation process and purified for therapeutic and non-therapeutic applications. Different classes of immunoglobulin such as IgG, IgA, and IgM are used for the treatment of various immunological and neurological diseases. These immunoglobulins can be administered intravenously and subcutaneously.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2586

The key companies profiled in the report include

• Baxter international Inc.,
• CSL Ltd,
• Grifols S.A,
• Octapharma AG,
• Kedrion Biopharma Inc.,
• LFB group,
• Biotest AG,
• China Biologics Products Inc.,
• BDI Pharma Inc., and
• Bayer Healthcare.

In 2016, North America accounted for maximum contribution to the total revenue generated, followed by Asia-Pacific. The major factors responsible for the growth of immunoglobulin market in these regions are the high adoption rate in developed and populous countries such as Japan and U.S. and the presence of large plasma production facilities.

Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.

Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market. However, high costs associated with the immunoglobulin treatment; shortage of immunoglobulin; and side effects of immunoglobulin treatment such as headache, migraine, fever, nausea or vomiting, and cough hinder the market growth. Immunoglobulin products are widely used for the treatment of immunodeficiency disease, ITP, chronic lymphocytic leukemia (CLL), and others. Rise in geriatric population, increase in patient population of blood disorders, and high healthcare expenditure are anticipated to boost the market growth.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/2586

Key Findings of the Immunoglobulin Market:

• Myasthenia Gravis segment is projected to grow at the fastest rate during the analysis period.
• Hypogammaglobulinemia was the highest revenue-generating segment, and is expected to continue its dominance in future.
• North America dominated global immunoglobulins market, and is projected to grow at a CAGR of 7.0% in terms of value.
• Saudi Arabia is expected to grow at the fastest rate in the LAMEA region, registering a CAGR of 11.8%. in terms of value.
• LAMEA segment was the fastest growing segment growing at a CAGR of 10.6% in terms of volume.

Table Of Content


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW OF IMMUNOGLOBULIN

3.2.1. Patented products

3.3. EPIDEMIOLOGY AND ECONOMIC BURDEN OF CHRONIC CONDITIONS
3.4. COST OF SIDE EFFECTS OF IMMUNOGLOBULIN TREATMENT
3.5. KEY FINDINGS

3.5.1. Top factors impacting
3.5.2. Top investment pockets

3.6. PORTER’S FIVE FORCES ANALYSIS
3.7. VALUE CHAIN ANALYSIS

3.7.1. Primary activities
3.7.2. Support activities

3.8. MARKET SHARE ANALYSIS, 2016
3.9. PRODUCT SCENARIO IN IMMUNOGLOBULIN MARKET
3.10. GOVERNMENT REGULATIONS AND REIMBURSEMENTS

3.10.1. U.S.
3.10.2. Europe

3.10.2.1. France
3.10.2.2. Germany
3.10.2.3. Italy

3.10.3. China
3.10.4. Japan
3.10.5. India

3.11. INDICATIONS FOR IMMUNOGLOBULIN

3.11.1. U.S. FDA indications
3.11.2. EMA

3.12. COMPONENT ANALYSIS OF IMMUNOGLOBULIN G (IGG)

3.12.1. IgG1
3.12.2. IgG2
3.12.3. IgG3
3.12.4. IgG4

3.13. CLINICAL TRIALS
3.14. MARKET DYNAMICS

3.14.1. Drivers

3.14.1.1. Rise in prevalence of immunodeficiency diseases
3.14.1.2. Increase in adoption of immunoglobulin
3.14.1.3. Increase in incidence of bleeding disorders
3.14.1.4. Surge in geriatric population

3.14.2. Restraints

3.14.2.1. Stringent government regulations
3.14.2.2. High cost of therapy

3.14.3. Opportunities

3.14.3.1. Opportunities in emerging economies
3.14.3.2. Development of cost-effective therapeutics through large-scale production

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/immunoglobulin-market.html

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.